JP2008530090A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530090A5
JP2008530090A5 JP2007555124A JP2007555124A JP2008530090A5 JP 2008530090 A5 JP2008530090 A5 JP 2008530090A5 JP 2007555124 A JP2007555124 A JP 2007555124A JP 2007555124 A JP2007555124 A JP 2007555124A JP 2008530090 A5 JP2008530090 A5 JP 2008530090A5
Authority
JP
Japan
Prior art keywords
cci
polymorph
solid
polymorph form
bme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007555124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530090A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/003098 external-priority patent/WO2006086172A1/en
Publication of JP2008530090A publication Critical patent/JP2008530090A/ja
Publication of JP2008530090A5 publication Critical patent/JP2008530090A5/ja
Withdrawn legal-status Critical Current

Links

JP2007555124A 2005-02-09 2006-01-25 Ｃｃｉ−７７９多形及びその使用 Withdrawn JP2008530090A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65137405P 2005-02-09 2005-02-09
PCT/US2006/003098 WO2006086172A1 (en) 2005-02-09 2006-01-25 Cci-779 polymorph and use thereof

Publications (2)

Publication Number Publication Date
JP2008530090A JP2008530090A (ja) 2008-08-07
JP2008530090A5 true JP2008530090A5 (enExample) 2009-03-05

Family

ID=36570939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007555124A Withdrawn JP2008530090A (ja) 2005-02-09 2006-01-25 Ｃｃｉ−７７９多形及びその使用

Country Status (19)

Country Link
US (1) US7442707B2 (enExample)
EP (1) EP1856130A1 (enExample)
JP (1) JP2008530090A (enExample)
KR (1) KR20070107030A (enExample)
CN (1) CN101115759A (enExample)
AR (1) AR052479A1 (enExample)
AU (1) AU2006213061A1 (enExample)
BR (1) BRPI0607932A2 (enExample)
CA (1) CA2595766A1 (enExample)
CR (1) CR9257A (enExample)
GT (1) GT200600044A (enExample)
IL (1) IL184560A0 (enExample)
MX (1) MX2007009590A (enExample)
NO (1) NO20073725L (enExample)
PE (1) PE20060996A1 (enExample)
RU (1) RU2007129264A (enExample)
TW (1) TW200638932A (enExample)
WO (1) WO2006086172A1 (enExample)
ZA (1) ZA200706628B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
RU2008120670A (ru) * 2005-12-07 2010-01-20 Вайет (Us) Масштабируемый способ получения 42-сложного эфира рапамицина из 42-сложного эфира рапамицина бороната
RU2008120712A (ru) * 2005-12-07 2010-01-20 Вайет (Us) Способы получения кристаллического рапамицина и определения кристалличности соединений рапамицина при помощи дифференциальной сканирующей калориметрии
KR20080077618A (ko) * 2005-12-07 2008-08-25 와이어쓰 정제된 결정체 ｃｃｉ-779 의 제조 방법
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
CN102282457A (zh) * 2009-01-21 2011-12-14 拜康有限公司 确定西罗莫司稳定性的方法和制备其稳定形式的工艺
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery
CN109020995A (zh) * 2017-06-12 2018-12-18 鲁南制药集团股份有限公司 一种替西罗莫司的晶型物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
TWI256395B (en) 1999-09-29 2006-06-11 Wyeth Corp Regioselective synthesis of rapamycin derivatives
CA2455311A1 (en) 2001-08-22 2003-03-06 Wyeth Rapamycin dialdehydes
EP1419154B1 (en) 2001-08-22 2005-10-05 Wyeth Rapamycin 29-enols
WO2005010010A1 (en) 2003-07-16 2005-02-03 Wyeth Cci-779 isomer c
PT1658295E (pt) * 2003-08-07 2007-09-25 Wyeth Corp Síntese regiosselectiva de cci-779
AU2004270154A1 (en) * 2003-09-03 2005-03-17 Wyeth Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
EP1737869A1 (en) * 2004-04-14 2007-01-03 Wyeth a Corporation of the State of Delaware Regiospecific synthesis of rapamycin 42-ester derivatives

Similar Documents

Publication Publication Date Title
RU2007104518A (ru) Полиморф рапамицина ii и его применение
KR101454937B1 (ko) 면역조절제로서 피리딘-3-일 유도체
KR101454944B1 (ko) Ｓ1ｐ1/ｅｄｇ 수용체 작동약으로서 아미노-피리딘 유도체
JP2005503386A5 (enExample)
JP2015521621A5 (enExample)
JP2018520178A5 (enExample)
JPH0631300B2 (ja) 結晶性アジスロマイシン２水和物及びその製法
JP2007532560A5 (enExample)
TW200920743A (en) New process for the synthesis of strontium ranelate and its hydrates
WO2013175506A2 (en) Process for sorafenib tosylate polymorph iii
JP2003527319A5 (enExample)
RU2007129264A (ru) Полиморф cci-779 и его применение
EP2537832B1 (en) Method for preparing (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate
CN107698574B (zh) 一种高纯度阿瑞匹坦的精制制备工艺
JP2022000462A (ja) エパルレスタットを調製する方法
CA2806820A1 (en) N-methylformamide solvate of dasatinib
JP2012521417A (ja) アデフォビルジピボキシルの新規結晶形及びその製造方法
JP2008524183A5 (enExample)
TW202313599A (zh) 式i化合物的晶型及其製備和應用
CA2734896A1 (en) Therapeutic substituted pyrroles
TH81761A (th) Cci-779 โพลีมอร์ฟ และ การใช้ของสารนั้น
US8552193B2 (en) Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide
JP2007510715A (ja) アトバコンの新規な多形およびその調製のプロセス
CN106432253B (zh) 一种维帕他韦新晶型及其制备方法
EP2139899A1 (en) Crystalline forms of topotecan hydrochloride and processes for making the same